SCHOLARLY PRODUCTIVITY Curriculum Vitae
Refereed Journal Articles
1. Osiecki-Newman K, Fabbro D, Dinu T, Boas SR, Gatt S, Legler
G, Desnick R, and Grabowski G. Human Acid Beta Glucosidase : Affinity
purification of the normal and Gaucher splenic enzymes on n-alkyl
deoxynorjirmycin sepharose. Enzyme 1986; 35:147-153.
2. Boas SR, Noyes BE, Kurland G, Armitage J, and Orenstein DM.
Pediatric lung transplantation for graft-versus-host disease following
bone marrow transplant. Chest 1994; 105:1584-1586.
3. Boas SR, Charron M, Ledesma-Medina J, Noyes BE, and Kurland
G. Hypertrophic osteoarthropathy in a child with follicular
bronchiolitis. Clin Nuclear Med 1995; 20(1):49-51.
4. Boas SR, Falsetti D, Murphy TD, and Orenstein DM. Validity
of self-assessment of sexual maturation in adolescents with cystic
fibrosis. J Adoles Health 1995; 17:42-45.
5. Faro A, Kurland G, Michaels MG, Dickman PS, Greally PG, Spichty
KJ, Noyes BE, Boas SR, Fricker J, Armitage J, and Zeevi A.
Alpha-interferon affects the immune response in post transplant
lymphoproliferative disorder. Am J Respir Crit Care Med 1996;
153:1442-1447.
6. Boas SR, Cleary DA, Lee PA, Orenstein DM. Salivary
testosterone levels in male adolescents with cystic fibrosis. Pediatrics
1996; 97:361-363.
7. Boas SR, Bloom MD, and Bonilla JA. Infantile laryngeal
neurofibroma presenting as stridor and dysphagia. Clin Pediatrics 1996;
35:151-153.
8. Boas SR, Joswiak ML, Nixon PA, Fulton JA, and Orenstein DM.
Factors limiting anaerobic performance in adolescent males with cystic
fibrosis. Med Sci Sports Exerc 1996; 28:291-298.
9. Boas SR, Kurland G, Greally PG, and Motoyama EK. Evolution
of airway hyperresponsiveness in congenital diaphragmatic hernia.
Pediatr Pulmonol 1996; 22:295-304.
10. Boas SR, Joswiak ML, Kurland G, Nixon PA, O'Connor MJ,
Bufalino K, Orenstein DM, and Whiteside TL. Effects of anaerobic
exercise on the immune system in 8 to 17 year old trained and untrained
males. J Pediatr 1996; 129:846-855.
11. Zapletal A, Kurland G, Boas SR, Noyes BE, Greally PG, Faro
A, Armitage JM, and Orenstein DM. Airway function tests and vocal cord
paralysis in lung transplant recipients. Pediatr Pulmonol 1997;
23:87-94.
12. Boas SR. Exercise recommendations in individuals with
cystic fibrosis. Sports Med 1997; 24:17-37.
13. Boas SR, Fulton JA, Koehler AN, Orenstein DM. Nutritional
and pulmonary function predictors of delayed puberty in adolescent males
with cystic fibrosis. Clin Pediatrics 1998; 37:593-596.
14. Saini SK, Boas SR, Jerath A, Roberts M, Greenberger PA.
Allergic bronchopulmonary mycosis to Fusarium vasinfectum in a child.
Ann Allergy Asthma Immunol 1998; 80:377-80.
15. Boas SR, Danduran MJ, Saini SK. Anaerobic exercise testing
in children with asthma. J Asthma 1998; 35:481-487.
16. Boas SR, Danduran MJ, McColley SA. Parental attitudes
about exercise in cystic fibrosis. Int J Sports Med 1999; 20:334-338.
17. Boas SR, Danduran MJ, McColley SA. Energy metabolism
during anaerobic exercise in children with cystic fibrosis and asthma.
Med Sci Sports Exerc 1999; 31:1242-1249.
18. Danduran MJ and Boas SR. Cystic fibrosis and exercise: A
case study and clinical application. Il Fysioterapista 2000; 6:36-41.
19. Boas SR, Danduran MJ, McColley SA, Beeman K, O'Gorman MRG.
Immune modulation following aerobic exercise in children with cystic
fibrosis. Int J Sports Med 2000; 21:294-301.
20. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE.
Serum vascular endothelial growth is elevated in cystic fibrosis and
decreases with treatment of pulmonary exacerbation. Am J Resp Crit Care
Med 2000; 161:1877-1880.
21. Boas SR, Danduran MJ, McColley SA, McBride A, Crawford S,
O'Gorman MRG. Postexercise immune correlates in children with and
without cystic fibrosis. Med Sci Sports Exerc 2000; 32:1997-2004.
22. Bare A, Vankoski SJ, Dias L, Danduran M, Boas SR.
Independent ambulators with high sacral myelomenigocele: the relation
between walking kinematics and energy consumption. Dev Med Child Neurol
2001; 43 (1):16-21.
23. Boas SR, McBride AL, Danduran MJ, McColley SA, Crawford
SE. Plasma vascular endothelial growth factor levels before and after
exercise in children with and without cystic fibrosis. (In Revision).
24. Boas SR, Nevin MA. The role of exercise in the diagnosis
and management of children with pulmonary disorders. Int Sports Med
Journal 2001; 2(5).
25. Boas SR, McBride A, Powers JD, Talley A. Montelukast
attenuates bronchoconstriction due to a combined exercise and cold air
provocation in children with mild asthma. (Submitted)
Books and Book Chapters
Boas SR and Danduran MJ. Cystic Fibrosis and Exercise. In:
Clinical Exercise Physiology. Jon Ehrman (Ed). Champaign, IL: Human
Kinetics 2000 (In Press).
Boas SR. Bronchiolitis Obliterans. In: Nelson Textbook of
Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2002,
17th Edition (In Press).
Boas SR. Neuromuscular and Skeletal Disease Affecting Pulmonary
Function. In: Nelson Textbook of Pediatrics, Richard Behrman (Ed).
Philadelphia, PA: WB Saunders 2002, 17th Edition (In Press).
Boas SR. Emphysema and Overinflation. In: Nelson Textbook of
Pediatrics, Richard Behrman (Ed). Philadelphia, PA: WB Saunders 2002,
17th Edition (In Press).
Proceedings and Non-Refereed Papers
1997 Boas, S.R. and S.A. McColley. Advances in Cystic Fibrosis. The
Child's Doctor 1997; 15.
Exhibits and Audio Visual Material
1995 Boas, S.R. Cystic Fibrosis and Exercise. (A Parent Educational
Booklet).
1998 Boas, S.R. Pediatric Flexible Bronchoscopy. A guide for patients
and families. (Educational Brochure)
1999 Boas, S.R. Exercise Induced Asthma. (A Parent Educational
Booklet).
Abstracts
26. Boas SR, Kurland G, Noyes BE, Orenstein DM, Atlas AB, and
Armitage J. Pneumothorax after transbronchial biopsy in pediatric lung
and heart-lung transplant recipients. Am Rev Respir Dis 1993; 147:(4)
A607. (Presented at the 1993 American Thoracic Society Annual
Conference).
27. Boas SR, Greally P, Kurland G, and Motoyama E. Development
of airway reactivity in neonates with congenital diaphragmatic hernia.
Am Rev Respir Dis 1994, 149:(4) A728. (Presented at the 1994 American
Thoracic Society Annual Conference).
28. Zapletal A, Greally P, Murphy TD, Boas SR, Faro A,
Orenstein D, Kurland G, and Armitage J. Airway function tests in the
assessment of vocal cord abnormalities in pediatric heart-lung and
double-lung transplant recipients. Am Rev Respir Dis 1994, (4) A738.
(Presented at the 1994 American Thoracic Society Annual Conference).
29. Greally P, Zapletal A, Boas SR, Orenstein DM, and Armitage
J. Longitudinal responses to beta agonists in pediatric heart lung and
double lung transplant recipients. Am Rev Respir Dis 1994, 149:(4) A732.
(Presented at the 1994 American Thoracic Society Annual Conference).
30. Boas SR, Joswiak ML, Bufalino K, O'Connor MJ, Nixon PA,
Orenstein DM, and Whiteside TL. Effects of anaerobic exercise on the
immune system in 8 to 17 year old trained and untrained males. Med Sci
Sports Exerc 1995, 27(5) Supplement. (Presented at the 1995 American
College of Sports Medicine Annual Conference).
31. Boas SR, Nixon PA, Joswiak M, Fulton J, and Orenstein DM.
Anaerobic exercise testing in male adolescents with cystic fibrosis. Ped
Ex Sci 1995,7(1):111. (Presented at the 1995 North American Society for
Pediatric Exercise Medicine Annual Conference).
32. Fulton J, Boas SR, Koehler A, and Orenstein D. Nutritional
and respiratory markers for pubertal development in adolescent males
with cystic fibrosis. Ped Pulm 1995, S12: 265. (Presented at the 1995
North American Cystic Fibrosis National Conference).
33. Danduran MJ, Boas SR, McColley SA, Gargan J, Wessel HU.
Parental attitudes about the benefits and barriers of exercise in
children with CF. Ped Pulm 1996, S336-7. (Presented at the 1996 North
American Cystic Fibrosis National Conference).
34. Sanai S, Boas SR, Danduran MJ. Normal anaerobic exercise
capacity in well-controlled asthmatic children. (Presented at the 1997
American Academy of Pediatrics, Section on Allergy and Immunology, 1997
Illinois Society of Allergy, Asthma, and Immunology).
35. Sanai SK, Boas SR, Danduran MJ. Altered anaerobic exercise
capacity in asthmatic children may contribute to impaired exercise
tolerance. J Allergy Clin Immun 1997;99:1672 (Presented at the 1997
AAAAI/AAI/CIS Joint Meeting).
36. Boas SR, Danduran MJ. Parental understanding about the
role of exercise in cystic fibrosis. Am J Resp Crit Care Med
1997,155:A646. (Presented at the 1997 American Thoracic Society Annual
Conference).
37. Boas SR, Danduran MJ, McColley SA. Preferential use of
aerobic pathways during anaerobic exercise in cystic fibrosis. Am J Resp
Crit Care Med 1997,155:A643. (Presented at the 1997 Chicago Thoracic
Society Scientific Abstract Session, 1997 American Thoracic Society
Annual Conference).
38. Boas SR, Danduran MJ. Correlation of aerobic and anaerobic
exercise in children with cystic fibrosis. Med Sci Sports Exerc 1997;
29: S209. (Presented at the 1997 American College of Sports Medicine
Conference).
39. Bare A, Vankoski S, Dias L, Danduran M, Boas SR. Energy
expenditure in children with lumbosacral myelomenigocele: What's the
cost of walking?
- Develop Med Child Neurol 1997; 39 (Suppl 75): 18. (Presented at
the 1997 American Academy for Cerebral Palsy and Developmental
Medicine Annual Meeting).
- Gait and Posture 1997; 5: 142-143. (Presented at the 1997 North
American Society for Gait and Clinic Movement Analysis).
40. Vankowski S, Bare BS, Dias L, Mitchaud S, Danduran M, Boas SR.
Energy expenditure, kinematics, and the center of mass during walking in
children with lumbosacral myelomenigocele. Gait and Posture 1997;
6:279-280.
41. Boas SR, Salazar JM, Danduran MJ, McColley SA. Effects of
ABreakpoints@ in normative values for pulmonary function in patients
with cystic fibrosis. Am J Resp Crit Care Med 1998,157:A128 (Presented
at the 1998 Chicago Thoracic Society Scientific Abstract Session, 1998
American Thoracic Society Conference).
42. Boas SR, Salazar JM, Danduran MJ, McColley SA. Diurnal
variations in pulmonary function within the cystic fibrosis population.
Am J Resp Crit Care Med 1998,157:A128 (1998 American Thoracic Society
Conference).
43. Boas SR, Chen RC, Danduran MJ, McColley SA, O'Gorman MRG,
Woods JA. Post exercise immune modulation in children with cystic
fibrosis. Am J Resp Crit Care Med 1998, 157: A128 (Presented at the 1998
Chicago Thoracic Society Scientific Abstract Session, 1998 American
Thoracic Society Conference).
44. McColley SA, Boas SR, Jain M, Qualter NA, O'Malley CA.
Patient adherence to and treatment satisfaction with an airway clearance
technique. Ped Pulm 1998, Suppl 17:389 (Presented at the 1998 North
American Cystic Fibrosis National Conference).
45. McColley SA, Stellmach V, Potter E, Huang J, Boas SR, Jain
M, Crawford SE. Serum vascular endothelial growth factor (VGEF) is
elevated in cystic fibrosis and is modulated by treatment of acute
pulmonary exacerbations. Ped Pulm 1998, Suppl 17:317 (Presented at the
1998 North American Cystic Fibrosis National Conference).
46. Boas SR, Schulz C, Weissberg-Benchell J, Martini DR,
McColley SA. Psychological screening in female adolescents with cystic
fibrosis. Ped Pulm 1998, Suppl 17:394 (Presented at the 1998 North
American Cystic Fibrosis National Conference).
47. Boas SR, Danduran MJ, Woods JA, O'Gorman MRG, McColley SA.
Post exercise catecholamine induced immunemodulation in children with
cystic fibrosis. Ped Ex Sci 1999,11(2):180. (1998 North American Society
for Pediatric Exercise Medicine Conference).
48. Danduran MJ, Boas SR, McBride AL. Biphasic responses to
exercise appear compromised in children with chronic pulmonary
disorders. Med Sci Sports Exerc 1999, 31(5):S330. (Presented at the 1999
American College of Sports Medicine Annual Conference).
49. McBride AL, Boas SR, Danduran MJ, Crawford, Huang L,
McColley SA. Serum vascular endothelial growth factor correlates with
fitness level in cystic fibrosis. Med Sci Sports Exerc 1999, 31(5):S270.
(Presented at the 1999 American College of Sports Medicine Annual
Conference).
50. McColley SA, Schulz C, Qualter N, Boas SR, Jain M, Goodman
DM. Participation in an observational study of airway clearance in
cystic fibrosis does not influence patient adherence. Ped Pulm 1999,
Suppl 19:331. (Presented at the 1999 North American Cystic Fibrosis
National Conference).
51. McColley SA, Harris CV, Qualter N, O'Malley C, Boas SR,
Jain M. Predictors of adherence to an airway clearance technique in
cystic fibrosis. Ped Pulm 1999, Suppl 19: 332. (Presented at the 1999
North American Cystic Fibrosis Conference).
52. McColley SA, Singhal A, Boas SR, Goodman DM. Inhaled
colistin for treatment of pulmonary exacerbation of cystic fibrosis. Am
J Resp Crit Care Med 2000, 161 (3):A73 (Presented at the 2000 American
Thoracic Society International Conference).
53. McBride AL, Danduran MJ, McColley SA, Boas SR. Is FEV1 a
good predictor of exercise tolerance in individuals with cystic
fibrosis. Ped Exerc Sci 2001, 13: 87-88. (Presented at the 2000 North
American Society for Pediatric Exercise Medicine International
Conference).
54. Danduran MJ, McBride AL, Holinger LD, Boas SR. Case
report: Unexplained dyspnea in a competitive female swimmer. Ped Exerc
Sci 2001, 13: 188 (Presented at the 2000 North American Society for
Pediatric Exercise Medicine International Conference).
55. Boas SR, Young J, McBride AM, McColley SA. The role of
mirtazepine as an appetite stimulant in children with cystic fibrosis.
Ped Pulm 2000, Suppl 20: 325-326. (Presented at the 2000 North American
Cystic Fibrosis Conference).
56. Boas SR, Salazar JM, McBride AL, Trousil JD. Feasability
and tolerance of simultaneous exercise and cold air provocation in
children with asthma. Am J Resp Crit Care Med 2001; 163 (5): A369.
(Presented at the 2001 American Thoracic Society Annual Conference).
57. McBride AL, Boas SR, Trousil J, McColley SA. The utility
of flow volume loop analysis during exercise in children with cystic
fibrosis. Med Sci Sports Exerc 2001, 33(5):S250. (Presented at the 2001
American College of Sports Medicine Annual Meeting).
58. Altemus C, Boas SR, Mesnik. Utilization of exercise tidal
loop analysis in children with exercise induced asthma. (Presented at
the 2001 World Asthma Meeting).
59. Miller ML, Boas SR. Evidence for deconditioning in
children with musculoskeletal pain syndromes. Arthritis Rheum 2001,
44(9): S171. (2001 American Rheumatology Meeting).
60. Boas SR, Talley AM, McBride AL, Mesnik MN. Montelukast
attenuates pulmonary decline during combined cold air/exercise
provocations in children with mild asthma. Med Sci Sports Exerc 2002,
34(5):S13. (Presented at the 2002 American College of Sports Medicine
Annual Meeting).
61. Trivunovic M, Miller ML, Mesnik M, Boas SR. Evidence for
deconditioning in children with musculoskeletal pain syndromes. Med Sci
Sports Exerc 2002, 34(5):S13. (Presented at the 2002 American College of
Sports Medicine Annual Meeting).
62. Mesnik MN, Boas SR. Early recovery oxygen kinetics
following a peak cardiopulmonary exercise test in children with cystic
fibrosis. Med Sci Sports Exerc 2002, 34(5):S14. (Presented at the 2002
American College of Sports Medicine Annual Meeting).
|
